Takeda Pharmaceutical Co. Ltd. · TSE:4502
Duprey Lauren Rusckowski sold 34,535 Takeda Pharmaceutical Co. Ltd. shares (Form 4)
Traded Sep 14, 2026 · Filed Sep 15, 2026
On Sep 14, 2026, Duprey Lauren Rusckowski (Chief Transformation Officer) sold 34,535 Takeda Pharmaceutical Co. Ltd. shares at US$18.54 for US$640K, leaving 191,522 shares. Filed Sep 15, 2026 (Form 4).
- Sold
- 34,535 shares
- Price
- US$18.54
- Value
- US$640K
- Holding after
- 191,522 shares
- Trading plan
- No
- Role
- Chief Transformation Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | American Depositary Shares | Sale | 34,535 | US$18.54 | 191,522 | Direct |
Source
Related
- Takeda Pharmaceutical Co. Ltd.
- Duprey Lauren Rusckowski
- Takeda Pharmaceutical Co. Ltd. shareholders
- Form 4 · Duprey Lauren Rusckowski · Aug 12, 2026
- Form 4 · Duprey Lauren Rusckowski · Jul 6, 2026
- Form 4 · Duprey Lauren Rusckowski · Apr 28, 2026
- Form 4 · Plump Andrew Stewart · Sep 3, 2026
- Form 4 · Plump Andrew Stewart · Aug 21, 2026
- Form 4 · Greenway Nicola Deidre Petal · Aug 19, 2026
- Form 4 · Shannon Elaine Mary · Aug 12, 2026
- Form 4 · Farajallah Awny Samaan Botros · Aug 12, 2026